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1. Introduction 
Atrial fibrillation is a relatively uncommon arrhythmia in childhood which is seen in a 
variety of pediatric clinical settings and continues to challenge health care providers.Atrial 
fibrillation may be seen at any age during childhood. Recent advances have allowed for 
prenatal diagnosis and treatment. Perinatal atrial fibrillation has been described, often in the 
absence of obvious structural or electrophysiological cardiac abnormality. In childhood, 
atrial fibrillation may be seen occasionally in association with cardiac tumors, myocarditis or 
cardiomyopathy. Certain medications and drug exposures may precipitate atrial fibrillation 
in children. Several congenital defects may be associated with atrial fibrillation in early 
adulthood, if left unrepaired or repaired or palliated with surgical or catheter intervention. 
The clinical significance of atrial fibrillation may range from trivial to life threatening, 
depending on the clinical setting and underlying electrophysiological or structural 
substrate. Recent research into the origins of atrial fibrillation, new drug therapy, 
interventional catheter and surgical procedures offer new treatment options for children or 
young adults at risk. This chapter reviews the recent advances in genetic, structural, 
electrophysiological, pharmacological, medical and surgical observations and the impact on 
understanding and management of this arrhythmia in children. 
2. Atrial embryology 
Atrial fibrillation is a relatively rare arrhythmia in the pediatric age group. But the 
antecedents for atrial fibrillation in adulthood are often the consequence of alterations in the 
developmental genetics, anatomy, function and electrical properties of the developing heart. 
Most of the information regarding the developing atrial conduction system comes from 
animal studies (Gourdie et al., 2003; Ho & Anderson, 1990; Jongbloed et al., 2004). The most 
useful model for the developing human cardiac conduction system concerns the rings of 
specialized tissue separating the five components of the primitive heart tube (at the juncture 
of the venous sinus, primitive atrium, inlet and outlet portions of the ventricular segment 
and the arterial segment). These rings form the primordial conduction system, a concept 
that can be extended to account for the ectopic distribution in malformed hearts (Gourdie et 
al., 2003; Ho & Anderson, 1990; Jongbloed et al., 2004). Among the atrial structures of the 
conduction system, the sinoatrial node is recognizable as early as the first stage of cardiac 
looping, at the juncture of the superior caval vein and the right atrium (Boyett, 2009; 
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Gourdie et al., 2003; Ho & Anderson, 1990; Jongbloed et al., 2004). The histologically discrete 
nodal cells are set in a connective tissue matrix, which increases in size toward birth. The 
remainder of the sinoatrial junction is infolded to form the valves of the venous sinus 
(Boyett, 2009; Gourdie et al., 2003; Ho & Anderson, 1990; Jongbloed et al., 2004). The sinus 
node was first identified by Sir Arthur Keith (suspected perpetrator of the Piltdown fraud) 
in 1907 (Boyett, 2009). Although textbooks show the sinoatrial node as a discrete nodule, 
electrophysiologic data and newer anatomic techniques suggest a more variable and 
extensive structure extending from the superior vena cava toward the inferior vena cava 
(Boyett, 2009; Dobrzynski et al., 2005; Scheussler et al., 1996). 
There is debate about whether significant connections exist between the sinoatrial nodal 
tissues and the atrioventricular node (Mommersteeg et al., 2009; Platanov, 2007; Sherf & 
James, 1979). Although illustrated in prior works, the circumferential muscle bundle located 
at the anterior wall of the left atrium connecting the right and left atrial appendages was 
named after George Bachmann, who described its participation in the interatrial 
propagation of electrical impulses in 1916 (Sherf & James, 1979). Recent embryologic studies 
in mice suggest that arrhythmogenic areas such as Bachmann’s bundle, the pulmonary veins 
and sinus venosus are intranodal structures which demonstrate lacZ gene expression, a 
characteristic of specialized conduction tissue (Boyett, 2009; Jongbloed et al., 2004; 
Mommersteeg, 2009; Platanov 2007).  
The atrioventricular node development is quite complex (Boyett, 2009; Gourdie et al., 2003; 
Ho & Anderson, 1990; Jongbloed et al., 2004). The ring of specialized tissue at the 
atrioventricular junction forms the primordium of the atrioventricular node. It is initially 
sandwiched between the atrioventricular sulcus and the endocardial cushion tissue (Boyett, 
2009; Gourdie et al., 2003; Ho & Anderson, 1990; Jongbloed et al., 2004). The conduction 
tissue on the inlet and apical trabecular components of the ventricular septum are brought 
together to form a continuous ventricular conduction axis. The endocardial cushions 
gradually regress, bringing the conduction bundle into direct contact with the inferior rim of 
the atrial septum (Boyett, 2009; Gourdie et al., 2003; Ho & Anderson, 1990; Jongbloed et al., 
2004). The atrial tissues immediately around the contact region become the transitional cell 
zone, while the end of the bundle becomes the compact atrioventricular node (Boyett, 2009; 
Gourdie et al., 2003; Ho & Anderson, 1990; Jongbloed et al., 2004). The atrioventricular node 
was first described in 1906 by Sunao Tawara working in Ludwig Aschoff’s laboratory in 
Germany (Boyett, 2009). Recent genetic work in animals and human beings suggest that 
mutations in the transcription factor Nkx2.5 may be associated with conduction system 
developmental abnormalities (Gittenberger-De Groot et al., 2007; Jay et al., 2004). 
The atrial and ventricular working myocardial cells are similar in characteristics but 
different in anatomic arrangement (Boyett, 2009; Gourdie et al., 2003;Ho & Anderson, 1990). 
These cells are characterized by a greater degree of depolarization at rest, no spontaneous 
pacemaker activity and rapid impulse conduction (Boyett, 2009; Gourdie et al., 2003;Ho & 
Anderson, 1990). Differentiation of conduction system elements from working atrial 
myocardial cells involves switching on and off controlling genes (Boyett, 2009). The 
transcription factor Tbx3 is expressed in the developing conduction system tissues and is 
usually turned off in working atrial myocytes (Boyett, 2009; Hoogaars et al., 2007). Working 
atrial myocardial cells have more efficient electrical coupling due to expression of genes 
controlling the connexion Cx43 in creating more and larger gap junctions (Boyett, 2009, 
Chandler et al., 2009). Cardiac conduction system cells have fewer and smaller gap junctions 
and express the connexion Cx45 instead (Boyett, 2009, Chandler et al., 2009). An 
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examination of messenger ribonucleic acid (mRNA) from human hearts show that sinoatrial 
and atrioventricular nodal cells have increased expression of hyperpolarization-activated 
cyclic nucleotide-gated channels, HCN4, (controlling If  current) and decreased expression of 
Kir channel genes, especially Kir2.1 (controlling IK,1 current) resulting in decreased resting 
potential, slower conduction and spontaneous depolarization through other ion channels 
(Boyett, 2009; Chandler et al., 2009; Hoogaars et al., 2007). The cardiac sodium channel, 
Nav1.5, (controlling INa current) is abundantly expressed in working myocardial cells but not 
in nodal tissue (Boyett, 2009).   Genetic issues, such as persistence of Tbx3 activity or 
acquired genetic alterations in ion channel function, may underlie the propensity to develop 
atrial fibrillation later in life (Hoogaars et al., 2007; Roberts & Gollob, 2010). 
3. Atrial genetics 
Recent reports suggest that channelopathies play a part to play in the development of atrial 
fibrillation (Darbar et al., 2008; Johnson et al., 2008; Kaufman, 2009; Patel & Pavri, 2009; 
Thejus & Francis, 2009). Atrial fibrillation may be associated with genes resulting in either 
ion channel gain-of-function or loss-of-function (Darbar et al., 2008; Johnson et al., 2008; 
Kaufman, 2009;Patel & Pavri, 2009;Thejus & Francis, 2009) and may be seen in 2% of patients 
with long QT syndrome, 10% of patients with Brugada syndrome and 30% of patients with 
short QT syndrome (Johnson et al., 2008; Patel & Pavri, 2009; Roberts & Gollob, 2010, Thejus 
& Francis, 2009). Familial atrial fibrillation has also been associated with identified 
channelopathies (Benito et al., 2008; Darbar et al., 2008; Johnson et al., 2008; Kaufman 
2009;Patel & Pavri, 2009;Roberts & Gollub, 2010; Thejus & Francis, 2009). Mutations 
involving ion transport associated with atrial fibrillation include SCN5A, KCNH2, KCNQ1, 
KCNJ2, KCNE2, KCNA5, HERG + MiRP1, KCNE1 and probably others (Benito et al., 2008; 
Darbar et al., 2008; Johnson et al., 2008; Kaufman 2009;Patel & Pavri, 2009;Thejus & Francis, 
2009). Although these mutations affect cardiac myocyte action potential height and 
duration, cellular repolarization duration and cardiac impulse conduction speed, the exact 
relation of ion channel abnormalities to atrial fibrillation development is unknown. The fact 
these genetic variants have been identified in families of patients with atrial fibrillation may 
facilitate new approaches to the diagnosis, prevention and treatment (Otway et al., 2007).   
Mechanisms other than enhanced atrial action potential repolarization (from gain-of-
function mutations) and delayed atrial action potential repolarization (from loss-of-function 
mutations) may be inherited. There has been a recent focus on hormonal control of atrial 
electrophysiology, including genes controlling atrial natriuretic peptide levels and 
mineralocorticoid receptor expression, in patients with atrial fibrillation (Hodgson-Zingman 
et al., 2008; Roberts & Gollob, 2010; Tsai et al., 2010). Re-expression of dormant fetal genes 
may be one mechanism associated with the development of atrial fibrillation in adults, as 
was demonstrated by the appearance of the fetal ssTnI isoform of troponin in patients with 
atrial fibrillation (Thijssen et al., 2004). These changes could be primary causes of atrial 
fibrillation or may represent secondary changes related to other changes in myocardial 
metabolism, function or distension. 
4. Atrial fibrillation in the fetus 
Atrial fibrillation in the fetus is rare, but not unheard of. Depending on the report, fetal atrial 
flutter or fibrillation accounts for somewhere between 20-33% of all fetal tachyarrythmias 
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(Azancot-Benistry et al., 1992; Belhassen et al., 1982; Silverman et al., 1985; Simpson et al., 
1998)and may be detected on routine obstetrical examination as an irregular or rapid fetal 
heart rate.  In general, any congenital heart disease may predispose to development of atrial 
fibrillation in this period, but several specific entities are generally considered higher risk. 
The Wolff-Parkinson-White (WPW) syndrome was first noted to have intrauterine atrial 
fibrillation and several other observations have come as fetal echocardiography has 
developed into a fully accepted clinical technique. Atrial septal defects, ventricular septal 
defects, atrioventricular canal, Ebstein anomaly, cor triatriatum and any single ventricular 
anatomy (most prominently hypoplastic left heart) are all felt to be higher than average risk 
for fetal atrial tachyarrythmia.  The most common arrythmia defined in several series is 
premature atrial contractions, which is most often benign, but has the potential to convert to 
an atrial tachyarrythmia (Belhassen et al., 1982; Silverman et al., 1985). Detection of fetal 
arrhythmia is primarily done clinically using ultrasound in most settings, and is well 
validated in multiple reports. Physiologic correlations have been demonstrated, the most 
severe of which is hydrops fetalis (Azancot-Benistry et al., 1992; Frohn-Mulder et al., 1995; 
Hajdu et al., 1997; Hansmann et al., 1991; Jaeggiet al., 1998; Kleinman et al., 1999; Matta et 
al., 2010; Naumburg et al., 1997; Reed et al., 1987; Soyeur D, 1996; Szabo et al., 1997; van 
Engelen et al., 1994; Zielinskyet al., 1998). As discussed above, familial atrial fibrillation has 
been noted to occur prenatally in the absence of hereditary structural heart disease, and may 
be indication for referral for high risk obstetrical screening (Aburawi et al., 2006; Bertram et 
al., 1996; Soyeur, 1996; Tikanoja et al., 1998).  
As the common pathway of hydrops fetalis is a devastating and often fatal diagnosis, early 
detection of fetal atrial flutter and other fetal supraventricular tachyarrhythmias is essential 
to prevention. The published mortality that has generally been attributed to fetal atrial 
flutter is in the 8-10% range, and while some have theorized that it is both harder to control 
and more likely to lead to fetal demise secondary to this phenomenon, a recent meta-
analysis of published data has shown that the overall risk of atrial flutter is similar to all 
other types of atrial tachyarrhythmia when taken together (Krapp et al., 2003). 
As fetal ultrasonography is essentially a mechanical observation of a presumed electrical 
phenomenon based upon our knowledge of extrauterine life, much research has been 
ongoing to refine techniques that will allow us to noninvasively monitor a fetus with 
suspected arrhythmia. One of the more exciting advances has been fetal 
magnetocardiography.  As magnetic resonance imaging (MRI) technology has advanced, 
cardiac MRI has become a viable field for extrauterine evaluation of the heart. To date, the 
motion artifacts associated with fetal movement have conspired to render fine detailed 
anatomic evaluation of the fetal cardiac structures as just a goal, but the physics of detecting 
the magnetic signature of the fetal electrical impulses have proven to be very promising, if 
somewhat cumbersome (Kahler et al., 2001; Wakai et al., 2003). Fetal magnetocardiography 
(fMCG) has advanced by leaps and bounds in recent years, and can be reliably performed 
beginning at 20 weeks gestation in the correct setting. The technique essentially takes 
advantage of the physical fact that electrical movement generates a magnetic field, and that 
when this magnetic field is affected by a second, focused and known magnetic field like an 
MRI scanner, the final vectors can be transformed to give an approximation similar to a 
surface ECG, which can then be interpreted similarly. This is a simplification of complex 
concepts and may give the impression that this technique should be readily and widely 
available. However, this technique, while promising, is currently only investigatory.  It is, 
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however, one of the few areas under investigation that would give us a potential leap 
forward in both detecting and understanding fetal arrhythmias. 
Many different treatments have been attempted and recommended for fetal atrial flutter and 
fibrillation, and this condition may be the most accurate representation of the medical 
truism that the greater the number of potential treatments, the less likely any one is to be 
successful.  The paradigm that is currently held is that any fetal tachycardia that is 
intermittent, present less than roughly half the time, and without obvious impact to the 
fetus, is followed closely but otherwise left untreated. (Cuneo & Strasburger, 2000).If 
treatment is indicated due to cardiac or valve dysfunction potentially leading to hydrops, 
the current mainstay of therapy at this time in the United States is digoxin. It has excellent 
ability to cross the placenta and has generally demonstrated good efficacy. For the same 
indications in Europe, the intervention of choice has become flecainide (Strasburger & 
Wakai, 2010).  For atrial flutter or fibrillation resistant to digoxin or flecainide in the absence 
of ventricular dysfunction, the current recommendation is to attempt to control the 
arrhythmia with sotalol and amiodarone (Cuneo & Strasburger, 2000;Srinivasan 
&Strasburger, 2008; Strasburger et al., 2004; Strasburger&Wakai, 2010). 
There have been several reports of alternative methods to maternal oral administration with 
varying degrees of success (Hallak et al., 1991; Parilla et al., 1996; Weiner et al, 1988), but 
most of these have been met without much general enthusiasm for the increased risk when 
the success rate of traditional therapy is in excess of 90% (Cuneo & Strasburger, 2000; 
Kleinman & Nehgme, 2004; Maeno et al., 2009; Srinivasan & Strasburger, 2008; Strasburger 
et al., 2004; Strasburger & Wakai, 2010). A recent report suggests that neurodevelopmental 
outcome for babies who experience fetal arrhythmias is very good (Lopriore et al., 2009). 
5. Atrial fibrillation in neonates 
The diagnosis of atrial fibrillation in the neonate is simpler than in the fetus due to the 
convenience of direct access to the patient. A 12-lead electrocardiogram can obtained and 
diagnostic accuracy greatly increased. Rarely is a neonatal invasive electrophysiological 
study indicated, but esophageal monitoring and pacing may be performed relatively easily.  
Additionally, the transition from the fetal circulation to the neonatal circulation puts added 
stretch and stress on the left atrium (and the pulmonary veins) due to lower pulmonary 
resistance and increased pulmonary blood flow. (Estlin et al., 1998; Larmay & Strasberger, 
2004). Two iatrogenic causes of atrial fibrillation or flutter may be seen in newborn infants. 
The most common of these is due to introduction of an umbilical venous catheter (UVC) into 
the right atrium.  It is not uncommon to find that even a carefully measured UVC line will 
end up in the right atrium and cause premature atrial contractions, atrial flutter or atrial 
fibrillation that will be intermittent and spontaneously resolve when the catheter is 
repositioned to outside of the atrium (da Silva & Waisberg, 2010; Sinha et al., 2005). A 
second major cause is exposure to the stress of surgical interventions in the neonatal period.  
If the neonate has structural heart disease, the incidence of atrial flutter or fibrillation is 
significantly higher, but less intuitive is the structurally normal heart of the infant that must 
undergo anesthesia and surgical correction of other conditions. Several case reports 
emphasize the variability with regard to underlying anatomic and electrophysiologic 
substrate and response to intervention (Bronzetti et al., 2009; Larmay & Strasburger, 2004; 
Mainzer et al., 2008). The sudden shifts in volume and potential cardiac effects of both 
inhaled and parenteral anesthetics associated with surgical intervention can easily overtax 
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even the normal neonatal heart and lead to arrhythmias, including atrial flutter and 
fibrillation. Intrathoracic procedures may add to this risk, with incidental mechanical 
contact with the neonatal atria triggering an arrhythmia.(Estlin et al., 1998; Gilbert-Barness 
& Barness 2006;Texter et al., 2006). 
The increased risk with neonates is not just limited to their small size and relative fragility, 
however.  It is felt that the immature myocardium, and specifically the atrioventricular node, is 
also more suited to conduct rapidly, and therefore set the neonate at particularly high risk for 
rapid ventricular response of any atrial tachyarrythmia, which in turn puts the infant at high 
risk for a sudden and precipitous drop in cardiac output. If the resultant cardiac output is 
insufficient for tissue oxygen delivery, the affected infant will then be at significant risk for 
both developing an irrecoverable rhythm and having end organ damage if the rhythm is not 
converted in a timely fashion.The largest study of neonates to date identified 50 children over 
a 25 year period that entered into atrial flutter (seen more often than atrial fibrillation in 
neonates) with no prior cardiac surgery and only an atrial septal defect found as an associated 
congenital defect (Texter et al., 2006). There were excellent results with electrical cardioversion 
(20 of 23, 87%), moderate success with transesophageal pacing (7of 22, 32%), and only 7 of 50 
(14%) who required chronic antiarrhythmic therapy. Of those experiencing recurrence of atrial 
flutter (6 of 50, 12%), all developed an additional supraventricular arrhythmia.  Most of the 
initial atrial flutter (36 of 50, 72%) presented within the first 48 hours of life, and the vast 
majority (5 of 6, 83%) of recurrent atrial flutter occurred within 24 hours of initial 
cardioversion.  There were an additional five infants who did not experience recurrent atrial 
flutter (10%) who developed a second supraventricular rhythm (Texter et al., 2006). 
Drugs which do not cross the placenta easily are now available for use in newborns if 
primary electrical cardioversion fails or the infant is in stable arrhythmia and the clinical 
decision to attempt chemical cardioversion as first line therapy is made. Adenosine may be 
useful in slowing the ventricular response (which may help identify the underlying 
arrhythmia) but may not be useful in terminating an atrial tachyarrhythmia. Ventricular rate 
may be slowed with beta blockade but hypotension and hypoglycemia are even more 
prevalent in the neonate than in older patients, and should be monitored closely when 
initiating therapy.  Regardless of initial therapy choice, atrialtachyarrhythmias may be 
difficult to control, and often may require trial and error prior to arriving at either the 
correct therapeutic drug or drug combination.  Once arrhythmia control is established, these 
patients may be allowed to “outgrow” their medication regimens after careful weight 
adjustment and monitoring as an outpatient for several months. As they mature, and the 
atrial conduction system matures, a large number of them have no reported recurrence. 
6. Atrial fibrillation in children with myocarditis, cardiomyopathy and cardiac 
tumors 
Infants and children make up a small percentage of patients presenting with atrial 
fibrillation (Martin, 2001). The seminal report of Radford and Izukawa on atrial fibrillation 
in children examined the spectrum of conditions associated with this arrhythmia (Radford & 
Izukawa, 1977). In the 35 cases of atrial fibrillation in children reported, associated 
conditions included rheumatic heart disease, cardiomyopathy, atrial tumors, infective 
endocarditis, Marfan syndrome, endocardial fibroelastosis and structural congenital heart 
disease (Radford & Izukawa, 1977). Cardiomyopathy (six patients), cardiac tumors (three 
patients), myocarditis and endocarditis (four patients) accounted for 37% of their reported 
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series. One specific type of myocarditis, acute rheumatic fever and subsequent rheumatic 
heart disease, has decreased to very low levels in developed countries, and will not be 
discussed in this review. 
Myocarditis, cardiomyopathy and cardiac tumors all can present with atrial fibrillation.  
Myocarditis is often the most difficult of these to diagnose and often requires a high level of 
clinical suspicion. Fulminant myocarditis can progress to a potentially fatal cardiac failure, 
often heralded by difficult to control arrhythmias, including atrial fibrillation (Ichikawa et 
al., 2011). The acute onset and probable viral etiology are keys in the history, but often 
myocarditis may present with only sudden onset atrial tachyarrhythmia. Resolution is often 
just as sudden if inflammation recedes and no myocardial scarring occurs. This is 
particularly the case if the inflamed myocardium is limited to the posterior left atrium. 
These children would have no findings other than the atrial fibrillation or flutter, possibly 
with clinical or laboratory evidence of a viral syndrome.  Even myocardial biopsies may be 
negative as they are rarely if ever taken from the atria due the extreme risk of this 
maneuver. Myocarditis may be suggested on pathological specimens (Chimenti et al., 2010; 
Frustaci et al., 1997). It is possible that cardiac MRI may be prove useful in the noninvasive 
diagnosis of myocarditis. There has been some controversy recently surrounding the 
generally held precept that atrial fibrillation in the setting of myocarditis is caused by the 
inflammation that is the hallmark of the disease. The potential exists that the arrhythmias 
are not caused by the active inflammation, but by the remodeling and healing process that 
comes after the inflammation recedes (Boos et al., 2006; Boos & Lip, 2008; McCabe et al., 
2008; Hoyano et al., 2010; Yap, 2009).  The progressive nature of atrial structural remodeling 
appears to underlie the progression of atrial fibrillation in other settings (de Vos et al, 2010; 
Wolf et al., 2009). 
Myocarditis in the setting of other structural or electrophysiologic abnormalities may 
present special issues. It has been postulated that atrial myocarditis and atrial 
tachyarrhythmias in the setting of ventricular pre-excitation may cause of sudden death in 
susceptible children and young adults (Basso et al., 2001). Myocarditis carries a higher risk 
for some children with congenital heart disease. Children with single ventricular physiology 
tend to be more reliant on atrial contraction to maintain cardiac output, and may have 
experienced extensive cardiac surgery. Atrial scarring also characterizes those having 
undergone atrial switch procedures. Extensive suture lines, atrial scarring, chronic stretch 
would increase the risk of inflammation and remodeling associated with myocarditis. 
Treating the underlying myocarditis may be needed to control persistent arrhythmia 
(Korantzopoulos et al., 2005). 
Myocarditis and cardiomyopathy may be linked with acute inflammation leading to chronic 
myocardial dysfunction. There are many cases of cardiomyopathy that do not follow 
myocarditis, however. Uncontrolled atrial tachyarrhythmias, particularly with rapid 
ventricular responses, can cause tachycardia-mediated cardiomyopathy. The genetics of 
cardiomyopathy and the genetics of atrial fibrillation are intertwined in complicated ways 
that are being identified. Some recent studies have shown links between cardiomyopathy 
and arrhythmia (Banwell et al., 1999; Karst et al., 2008; McNair et al., 2011). All types of 
cardiomyopathy have the potential for arrhythmia. Similar to children with single ventricle 
physiology, those with cardiomyopathy are dependent on upon atrial contraction for 
cardiac output. As atrial pressure, stretch, and remodeling occur with deterioration in 
ventricular function, the frequency of atrial fibrillation increases. The stress on the atrial 
chamber increases the potential for atrial inflammation and progression to a noninfectious 
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atrial myocarditis (Hsu, 2010). Atrial fibrillation has been shown to be a major clinical risk 
factor for morbidity in hypertrophic cardiomyopathy (Kubo et al., 2009). 
Cardiac tumors are both easier to understand and diagnose.  The infamous “tumor plop” 
may be present on physical exam. They may obstruct flow into the ventricular cavity, or 
become caught in the atrioventricular valve causing significant regurgitation. Tumors are 
easily recognizable using echocardiography by their distinct appearance. Depending on the 
type and location of the tumor, symptoms will vary. Intracardiac tumors which are 
myxomatous may be pedunculated and mobile, and may swing wildly around the affected 
atria, potentially bouncing off the interior walls and inciting atrial fibrillation by this contact 
(Vermeulen et al., 2009; Yu et al., 2006). The treatment for these tumors is predominantly 
surgical, and reasonable success has been obtained in this manner (Chuaratanaphong et al., 
1995; Ipek et al., 2005).Cardiac rhabdomyomas are a hallmark of tuberous sclerosis, and 
their natural history is that they recede from the time of birth onward.  They rarely require 
intervention unless they are so large that they obstruct the flow of blood, typically by 
encompassing so much of the myocardium that they impede filling of the ventricles. These 
can easily be detected prenatally if they are of sufficient size. Atrial tachyarrhythmias may 
occur when the tumors involve the atrial walls. They may interfere with atrial 
depolarization or conduction leading to atrial flutter or fibrillation (Yamashita et al., 1987).  
Tumors involving the heart, but not originating there, may be associated with atrial 
fibrillation. Cardiac effects may be due the high output states, inflammatory or 
chemotherapeutic processes, or direct tumor infiltration of cardiac chambers of the 
myocardium. Hypercoagulability may be associated with neoplasia, and combined with 
atrial fibrillation may predisposes to embolic phenomenon from potential mural wall 
thrombus formation or murantic endocarditis. Benign tumors that arise in the pericardium 
may also cause mechanical pressure on the atria due to the limited space available to them 
to grow.  All of these may lead to atrial fibrillation, and the resulting clinical impact (Chen et 
al., 1992; Cooper et al., 1994; Radford & Izukawa, 1977).  
7. Atrial fibrillation in children without structural heart disease 
Radford and Izukawa noted that atrial fibrillation in childhood may occur at any age, with 
nearly 50% of those reported by presenting after age 10 years (Radford & Izukawa, 1977). In 
describing the children with this arrhythmia, they described four cases of atrial fibrillation 
associated with supraventricular tachycardia (without structural heart disease) and one case 
of “lone” atrial fibrillation (Radford & Izukawa, 1977). Atrial fibrillation in the absence of 
structural heart disease, or “lone” atrial fibrillation, accounted for 6% of the older children in 
this series. Recent reports in adolescents and young adults suggests that “lone” atrial 
fibrillation may be associated with an abnormal atrial electrophysiologic substrate, and may 
not be as “lone” as previously suspected (Holmqvist et al., 2011; Korantzopoulos et al., 2009; 
Stiles et al., 2009). One case of lone atrial fibrillation with complete heart block in a ten year 
old boy has been reported, suggesting the possibility of more generalized conduction 
system dysfunction (Krishna Kumar et al., 1991). In a report of nine adolescents with “lone” 
atrial fibrillation, irregular rapid atrial tachycardias in the region of the pulmonary veins, 
left atrium and crista terminalis were noted (Nanthakumar et al., 2004), suggesting the 
possibility of congenital abnormalities in impulse initiation or conduction in these areas. 
Recently, a single nucleotide polymorphism has been identified that is associated with 
prolonged atrial conduction and lone atrial fibrillation in young adults (Goodloe et al., 2011) 
www.intechopen.com
 
Atrial Fibrillation in Children 357 
Atrial fibrillation has also been reported in adolescents without known cardiac disease 
experiencing the “holiday heart” phenomenon (Koul et al., 2005; Thorton, 1984). The holiday 
heart consists of atrial fibrillation occurring after binge alcohol consumption in young 
people without underlying disease or cardiac abnormalities (Koul et al., 2005; Thorton, 
1984). Chronic alcohol consumption is also associated with an increased risk of atrial 
fibrillation and has been reported in some adolescents (Kodama et al., 2011). The use of 
alcohol with other illicit drugs has also been linked with atrial fibrillation in young adults 
(Krisnamoorthy et al., 2009). The use of highly caffeinated beverages by adolescents, a 
popular new phenomenon, is another reported association (Di Rocco et al., 2011). Obesity 
appears to be a risk factor for atrial fibrillation in younger adults, and the epidemic of 
obesity in children may represent an increasing risk factor (Guglin, et al., 2011; Niemann, et 
al. 2011). Additional types of mayhem have been linked to atrial fibrillation in adolescents. 
There was one report of atrial fibrillation after Taser exposure in an adolescent who tested 
positive for marijuana (Multerer et al., 2009). Scorpion bite has been linked to cardiac 
disorders including atrial fibrillation (Alan et al., 2004). 
Prescribed medication use may be associated with atrial fibrillation in children without 
structural heart disease. The use of corticosteroids, taken orally and inhaled, has been linked 
to atrial fibrillation in children (Huerta et al., 2005; Oteri et al., 2010; Ueda et al., 1988; 
Yamamura et al., 2011). There is one report of a child with hyperthyroidism presenting with 
atrial fibrillation (Perry & Hung, 1971). The low frequency of these reported associations 
would suggest that a genetic propensity toward atrial fibrillation may have been present in 
the affected individuals. 
Atrial fibrillation associated with the WPW syndrome may be life threatening (Paul et al., 
1990; Piertersen et al., 1992). Conduction from the fibrillating atria via an accessory 
atrioventricular connection with a short refractory period may lead to ventricular fibrillation 
(Brembilla-Perrot et al., 2010; Paul et al., 1990; Piertersen et al., 1992; Sarubbi, 2006). One of 
the difficulties is determining which of the children with pre-excitation on their 
electrocardiograms are at risk. In one reported series, spontaneous atrial fibrillation was 
seen in 4% of children with WPW syndrome, with 22% of children demonstrating atrial 
fibrillation during electrophysiologic study (Lee et al., 2004). Degeneration of 
supraventricular tachycardia into atrial fibrillation was seen in 51% of 53 young patients 
with WPW syndrome, with 34% having a rapid ventricular response rate (Harahsheh et al., 
2008). In another study of 62 asymptomatic children with pre-excitation on their 
electrocardiogram, supraventricular tachycardia was initiated in 58% and atrial fibrillation 
was observed in 13% (Sarubbi et al., 2005). In a prospective study of asymptomatic children 
with WPW syndrome, arrhythmias were seen in 51 of 184 patients, 19 of which were life-
threatening including three patients with syncope and three with cardiac arrest (Santinelli et 
al., 2009). Risk factors for life-threatening arrhythmias included a short antegrade effective 
refractory period for the accessory atrioventricular connection (< 240 msec) and multiple 
accessory atrioventricular connections (Santinelli et al., 2009). Most pediatric 
electrophysiologists recommend invasive electrophysiologic testing to stratify risk and 
assess the need for radiofrequency or cryotherapy catheter ablation of the accessory 
atrioventricular connection in asymptomatic children with manifest pre-excitation 
(Campbell et al., 2003, Lee et al., 2006; Santinelli et al., 2006). Some children presenting with 
recurrent atrial fibrillation have supraventricular tachycardia unrelated to pre-excitation or 
the WPW syndrome as a triggering event and they may be successfully treated by catheter 
ablation of their supraventricular tachycardia substrate (Streiper et al., 2010). 
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8. Atrial fibrillation in children with structural heart disease 
Nearly half of the cases of atrial fibrillation in children and young adults are associated with 
congenital heart disease (Radford & Izukawa, 1977). Congenital heart defects may be 
associated with atrial arrhythmias either before or after surgical correction (Attenhofer Jost 
et al., 2005; Berger et al., 2005; Bouchardy et al., 2009; Chatzis et al., 2008; Chauvaud et al 
2001; Collins, 2009; Hallioglu et al., 2004; Hayashi et al, 2006; Kammeraad et al., 2004; 
Kaseno et al., 2008; Khairy et al., 2010;Khositeth et al., 2004; Luciani et al., 2008; Marelli et al;, 
2010; Massin et al., 2010; Porter & Garson, 1993; Radford & Izukawa, 1977; Saul, 2008; Spies 
et al., 2008; Sugimoto et al., 2001, Trojnarska et al., 2009). Those congenital heart defects 
occurring in conjunction with atrial fibrillation include those associated with abnormalities 
in the development of the cardiac conduction system, abnormalities in the development of 
atrial structure, abnormalities in flow resulting in atrial enlargement, abnormalities in 
impulse initiation or conduction from surgical atrial scarring. The risk factors for developing 
atrial fibrillation originate in early in life but not become manifest until adulthood.  
Congenital heart defects that are most often associated with atrial fibrillation include atrial 
septal defect, Ebstein anomaly, anomalies in pulmonary venous drainage, transposition of 
the great arteries, single ventricle, tetralogy of Fallot and Marfan syndrome (Attenhofer Jost 
et al., 2005; Berger et al., 2005; Bouchardy et al., 2009; Chatzis et al., 2008; Chauvaud et al 
2001; Collins, 2009; Hallioglu et al., 2004; Hayashi et al, 2006; Kammeraad et al., 2004; 
Kaseno et al., 2008; Khairy et al., 2010; Khositeth et al., 2004; Luciani et al., 2008; Marelli et 
al;, 2010; Martin et. al., 1983; Massin et al., 2010; Porter & Garson, 1993;Radford & Izukawa, 
1977; Saul, 2008;Spies et al., 2008; Sugimoto et al., 2001; Trojnarska et al., 2009). Atrial 
fibrillation has also been seen following heart transplantation in pediatric patients (Collins 
et al., 2003). Risk factors for atrial fibrillation in congenital heart disease include age at 
operation, atrial dilatation from intra-cardiac shunting, atrial dilatation from valve 
insufficiency, extensive atrial suture lines and ventricular myocardial dysfunction. Recent 
advances in pediatric heart disease management include repair of congenital defects at 
younger ages, percutaneous catheter and device intervention to avoid complications of 
cardiac bypass, modifications of surgery to avoid atrial scarring and more aggressive 
management of residual regurgitant valve lesions. The hope is that these changes will 
decrease the burden of atrial fibrillation associated with congenital heart disease.  
9. Management of atrial fibrillation in children 
The diagnosis of atrial fibrillation in childhood is not difficult in most instances. Intravenous 
adenosine and transesophageal electrode recording can be used to assist in the diagnosis 
(Fazio et al., 2008; Gewitz & Woolf, 2006; Kaltman & Shah, 2004). Guidelines are available 
for treatment of atrial fibrillation in adults, and with modifications, provide a framework for 
treating children with the arrhythmia (American College of Cardiology/American Heart 
Association/European Society of Cardiology, 2006; American College of Cardiology 
Foundation/American Heart Association/Heart Rhythm Society (ACCF/AHA/HRS), 
2011). Emergency management of children with significant hemodynamic compromise 
would include electrical cardioversion (Gewitz & Woolf, 2006; Kaltman & Shah, 2004). In 
more stable children, the use of intravenous beta-adrenergic blocker (eg, esmolol, 
propranolol) or calcium channel blocker (eg. verapamil, diltiazem) could be used to slow the 
ventricular response rate (Fazio et al, 2008; Gewitz & Woolf, 2006; Kaltman & Shah, 2004). 
See table for a listing of useful drugs in the management of atrial fibrillation in children. 
Intravenous digoxin or amiodarone could be used emergently and continued on a chronic 
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Table 1. Useful drugs in the management of atrial fibrillation in infants and children. 
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basis if needed (Fazio et al, 2008; Gewitz & Woolf, 2006; Kaltman & Shah, 2004). Other drugs 
available for the management of acute and chronic atrial fibrillation in children include 
sotalol, propafenone, procaineamide, flecainide, ibutilide, and dofetilide (Gewitz & Woolf, 
2006; Kaltman & Shah, 2004; Fazio et al, 2008). In patients with WPW syndrome, digoxin 
and verapamil should not be used due to tendency to increase antegrade conduction via the 
accessory atrioventricular connection (Byrum et al, 1982; Fazio et al, 2008; Gewitz & Woolf, 
2006; Kaltman & Shah, 2004; Rowland, 1983). If elective cardioversion is needed, 
transeosophageal or transthoracic echocardiography will be needed to assess the need for 
anticoagulation prior to the procedure (ACC/AHA/ESC, 2006; Fazio et al, 2008; Gewitz & 
Woolf, 2006; Horenstein et al, 2004; Kaltman & Shah, 2004). Long term oral anticoagulation 
with coumadin may be need in high risk pediatric patients with chronic or recurrent atrial 
fibrillation. 
The demonstrated success of the Maze procedure for the surgical treatment of atrial 
fibrillation (Cox et al., 1991; Cox, 2010) and the development of subsequent percutaneous 
catheter ablation techniques (Haissaguerre et al., 1998; Weerasooriya et al., 2011) have led to 
new options in the management of atrial fibrillation. Arrhythmia surgery has been 
successful in children with and without congenital heart disease (Deal et al, 2003). 
Congenital heart defects associated with arrhythmias have been successfully treated with 
combined surgical and ablative procedures (Deal et al., 2003; Fujita et al., 2009; Greason et 
al., 2003; Mavroudis et al., 2008; Stulak et al., 2006; Therrien et al., 2001). These new 
techniques allow for an individual approach tailored to the needs of specific patients 
(Brenyo & Aktas, 2011). Recurrence of atrial fibrillation following surgical or catheter 
ablation remains a risk and the need for oral anticoagulation is being debated 
(Themistoclakis et al, 2010). Newer drugs (eg, dabigatran) for long-term anticoagulation 
may be useful in some childhood cases of atrial fibrillation (Dahl & Huisman, 2010).  
10. Prognosis 
No prospective long-term follow-up is reported in children with atrial fibrillation. Children 
in the newborn period with no underlying disease have an excellent prognosis, as do those 
older patients with a triggering event or disease which is reversible. Lone atrial fibrillation 
in older children and young adults has a good outcome. Patients with atrial fibrillation 
associated with abnormal cardiac structural, functional or electrophysiologic substrate have 
a variable outcome. Newer drugs offer clinical improvement on a short term basis but long-
term outcomes, especially for children, are not available. Surgical and catheter management 
techniques continue to offer a new alternative, but no long-term follow-up in young patients 
is available. 
11. Conclusions 
Atrial fibrillation is a relatively uncommon arrhythmia in childhood. It may be associated 
with genetic, electrophysiologic and structural variables that are present from the prenatal 
period. It may become manifest early in life under conditions of infection, neoplasia, 
structural, functional or electrical cardiac disease. It may be seen in the absence of cardiac 
disease in metabolic, infectious or systemic disease. Drug or alcohol exposure, electric shock 
or scorpion envenomation may precipitate an attack. Diagnosis and treatment will vary with 
age, electrophysiologic and anatomic substrate and clinical status. Newer diagnostic tools, 
pharmacologic therapies, surgical and catheter procedures allow for individualized 
approach in this interesting group of patients. 
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